glp-1 drugs news today now have new guidelines How are GLP-1 drugs reshaping

For the first time in the history of obesity medications we see weight loss efficacy of a magnitude that might raise concern about excessive loss of lean body tissue due to the initial pronounced reduction in energy intake and subsequent risk of protein deficiency

Then you have weight maintenance, which is the rest of your life because it's a chronic relapsing disease if you will or condition

Waiting less than 30 minutes or taking with food or beverages other than plain water will lessen the effect of the medication

Similarly, an alternative dosage form of liraglutide, Saxenda, was recently approved to treat obesity [179], and is currently the only GLP-1 RA approved in for this indication

[DOI] [PubMed] [Google Scholar] 84.Sun F, Shanshan W, Wang J, Guo S, Chai S, Yang Z, Li L, Zhang Y, Ji L, Zhan S